A special master overseeing opioid litigation is resisting a request to step down after he mistakenly sent lawyers a “reply all” email with private notes to himself.
Republican Indiana Attorney General Todd Rokita is facing ethics charges for comments that he made about his investigation of an “abortion activist acting as a doctor” who provided an abortion to a 10-year-old girl.
Updated: The U.S. government likely violated the First Amendment by pressuring social media companies to block COVID-19 misinformation and other content, a federal appeals court ruled Friday.
The top court in Massachusetts has ruled that a school for developmentally and intellectually disabled people can continue to use electric skin shock therapy as permitted by a 1987 consent decree.
While family separations have long been the norm when treating babies born dependent on substances, recent research suggests allowing a mother to stay with and care for her infant significantly improves their health outcomes.
Doctors who prescribed the human version of a drug called ivermectin to thousands of their COVID-19 patients can sue the U.S. Food and Drug Administration, a federal appeals court has ruled.
Yale University has settled a federal lawsuit with a student group alleging that the school discriminated against students with mental health issues and pressured them to withdraw from classes.
A federal appeals court has ruled in favor of a Louisiana man who was arrested after posting on Facebook that a local sheriff’s department had ordered its deputies to shoot people who were infected with COVID-19.
It's time for The Modern Law Library's summer recommendations episode, in which host Lee Rawles shares her pop culture picks with you, plus a re-airing of one of our older episodes with current relevance.
BigLaw attorneys cite unreasonable or excessive demands from clients as a primary reason for their stress and anxiety, according to a survey by the American Lawyer on mental health in the legal profession.
The U.S. Food and Drug Administration failed to address safety concerns when it expanded access to the abortion drug mifepristone in 2016 and 2021, according to the 5th U.S. Circuit Court of Appeals at New Orleans.
The ABA Journal wants to host and facilitate conversations among lawyers about their profession. We are now accepting thoughtful, non-promotional articles and commentary by unpaid contributors.